Cargando…
Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study
BACKGROUND: The incidence rate of adenocarcinoma of the esophagogastric junction (AEG) has significantly increased over the past two decades. Surgery remains the only curative treatment. However, there are currently few studies on Chinese AEG patients. The purpose of this study was to retrospectivel...
Autores principales: | Feng, Yiding, Jiang, Youhua, Zhao, Qiang, Liu, Jinshi, Zhang, Hangyu, Chen, Qixun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706258/ https://www.ncbi.nlm.nih.gov/pubmed/33256690 http://dx.doi.org/10.1186/s12893-020-00926-1 |
Ejemplares similares
-
Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: Erratum
Publicado: (2017) -
Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction
por: Xu, Jinming, et al.
Publicado: (2017) -
Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction
por: Tian, Yuan, et al.
Publicado: (2021) -
Short-Term and Long-Term Outcomes Following Transhiatal versus Right Thoracoabdominal Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction
por: Xing, Jiadi, et al.
Publicado: (2020) -
The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients
por: Goto, Hironobu, et al.
Publicado: (2014)